Development of a comorbidity index using physician claims data

被引:1648
作者
Klabunde, CN
Potosky, AL
Legler, JM
Warren, JL
机构
[1] NCI, Hlth Serv & Econ Branch, Appl Res Program, Div Canc Control & Populat Sci, Bethesda, MD 20892 USA
[2] NCI, Stat Res & Applicat Branch, Surveillance Res Program, Div Canc Control & Populat Sci, Bethesda, MD 20892 USA
关键词
comorbidity; claims data; administrative data; Medicare; breast cancer; prostate cancer;
D O I
10.1016/S0895-4356(00)00256-0
中图分类号
R19 [保健组织与事业(卫生事业管理)];
学科分类号
摘要
Important comorbidities recorded on outpatient claims in administrative datasets may be missed in analyses when only inpatient care is considered. Using the comorbid conditions identified by Charlson and colleagues, we developed a comorbidity index that incorporates the diagnostic and procedure data contained in Medicare physician (Part B) claims. In the national cohorts of elderly prostate (n = 28,868) and breast cancer (n = 14,943) patients assessed in this study, less than 10% of patients had comorbid conditions identified when only Medicare hospital (Part A) claims were examined. By incorporating physician claims, the proportion of patients with comorbid conditions increased to 25%. The new physician claims comorbidity index significantly contributes to models of 2-year noncancer mortality and treatment received in both patient cohorts. We demonstrate the utility of a disease-specific index using an alternative method of construction employing study-specific weights. The physician claims index can be used in conjunction with a comorbidity index derived from inpatient hospital claims, or employed as a stand-alone measure. (C) 2000 Elsevier Science Inc. All rights reserved.
引用
收藏
页码:1258 / 1267
页数:10
相关论文
共 43 条
  • [1] *AM MED ASS, 1995, PHYS CURR PROC TERM
  • [2] [Anonymous], 1992, MANUAL STAGING CANC
  • [3] Factors associated with surgical and radiation therapy for early stage breast cancer in older women
    BallardBarbash, R
    Potosky, AL
    Harlan, LC
    Nayfield, SG
    Kessler, LG
    [J]. JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1996, 88 (11): : 716 - 726
  • [4] BENNETT CL, 1991, CANCER, V67, P2633, DOI 10.1002/1097-0142(19910515)67:10<2633::AID-CNCR2820671039>3.0.CO
  • [5] 2-9
  • [6] A NEW METHOD OF CLASSIFYING PROGNOSTIC CO-MORBIDITY IN LONGITUDINAL-STUDIES - DEVELOPMENT AND VALIDATION
    CHARLSON, ME
    POMPEI, P
    ALES, KL
    MACKENZIE, CR
    [J]. JOURNAL OF CHRONIC DISEASES, 1987, 40 (05): : 373 - 383
  • [7] Evaluation of two competing methods for calculating Charlson's comorbidity index when analyzing short-term mortality using administrative data
    Cleves, MA
    Sanchez, N
    Draheim, M
    [J]. JOURNAL OF CLINICAL EPIDEMIOLOGY, 1997, 50 (08) : 903 - 908
  • [8] Cornoni-Huntley J C, 1991, Int J Epidemiol, V20 Suppl 1, pS8
  • [9] Factors that determine the treatment for local and regional prostate cancer
    Desch, CE
    Penberthy, L
    Newschaffer, CJ
    Hillner, BE
    Whittemore, M
    McClish, D
    Smith, TJ
    Retchin, SM
    [J]. MEDICAL CARE, 1996, 34 (02) : 152 - 162
  • [10] ADAPTING A CLINICAL COMORBIDITY INDEX FOR USE WITH ICD-9-CM ADMINISTRATIVE DATABASES
    DEYO, RA
    CHERKIN, DC
    CIOL, MA
    [J]. JOURNAL OF CLINICAL EPIDEMIOLOGY, 1992, 45 (06) : 613 - 619